Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000047677
JPRN-UMIN000047677Recruiting未知

Exploratory study of genome alteration and rearrangement associated with ART (Assisted Reproductive Technology) using birth and three-generation cohort study (TMM BirThree Cohort Study). - Exploratory study of genome alteration and rearrangement associated with ART (Assisted Reproductive Technology) using birth and three-generation cohort study (TMM BirThree Cohort Study).

Tohoku Medical Megabank Organization0 sites6 target enrollmentStarted: May 10, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
6
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Not applicable

Investigators

Sponsor
Tohoku Medical Megabank Organization

Similar Trials

Active, not recruiting
Not Applicable
Immune micro-environment and immune genomics of head and neck cancer
CTRI/2018/07/014757Department of Biotechnology Systems Medicine Cluster SyMeC Kolkata
Recruiting
Not Applicable
A biomarker study to analyze genomic variations in circulating-tumor DNA and circulating tumor cells in gastrointestinal cancers (Valor trial)Gastrointestinal cancer
JPRN-UMIN000036681St. Marianna University School of Medicine Hospital70
Not yet recruiting
Not Applicable
The investigation of comprehensive genetic mutation in patients with ulcerative colitis.ulcerative colitis
JPRN-UMIN000024589Chiba university50
Recruiting
Not Applicable
The study of gene and epigenetic modifications, bioelement and physical active substance on the patients with neurodegenerative diseases.eurodegenerative diseases
JPRN-UMIN000030101Gifu Pharmaceutical University100
Active, not recruiting
Not Applicable
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.
EUCTR2010-021120-96-GBRoche Products Limited1,200